Skip to main content
Top
Published in: BMC Infectious Diseases 1/2006

Open Access 01-12-2006 | Research article

Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico

Authors: Cosme Alvarado-Esquivel, Antonio Sifuentes-Álvarez, Sergio Guadalupe Narro-Duarte, Sergio Estrada-Martínez, Juan Humberto Díaz-García, Oliver Liesenfeld, Sergio Arturo Martínez-García, Arturo Canales-Molina

Published in: BMC Infectious Diseases | Issue 1/2006

Login to get access

Abstract

Background

Toxoplasma gondii (T. gondii) infection in pregnant women represents a risk for congenital disease. There is scarce information about the epidemiology of T. gondii infection in pregnant women in Mexico. Therefore, we sought to determine the prevalence of T. gondii infection and associated socio-demographic, clinical and behavioural characteristics in a population of pregnant women of Durango City, Mexico.

Methods

Three hundred and forty three women seeking prenatal care in a public hospital of Durango City in Mexico were examined for T. gondii infection. All women were tested for anti-T. gondii IgM and IgG antibodies by using IMx Toxo IgM and IMx Toxo IgG 2.0 kits (Abbott Laboratories, Abbott Park, IL, USA), respectively. Socio-demographic, clinical and behavioural characteristics from each participant were also obtained.

Results

Twenty one out of the 343 (6.1%) women had IgG anti-T. gondii antibodies. None of the 343 women had IgM anti-T. gondii antibodies. Multivariate analysis using logic regression showed that T. gondii infection was associated with living in a house with soil floor (adjusted OR = 7.16; 95% CI: 1.39–36.84), residing outside of Durango State (adjusted OR = 4.25; 95% CI: 1.72–10.49), and turkey meat consumption (adjusted OR = 3.85; 95% CI: 1.30–11.44). Other characteristics as cat contact, gardening, and food preferences did not show any association with T. gondii infection.

Conclusion

The prevalence of T. gondii infection in pregnant women of Durango City is low as compared with those reported in other regions of Mexico and the majority of other countries. Poor housing conditions as soil floors, residing in other Mexican States, and turkey meat consumption might contribute to acquire T. gondii infection.
Literature
1.
go back to reference Liesenfeld O, Janitschke K: Toxoplasma. Medizinische Mikrobiologie und Infektiologie. Auflage. Edited by: Hahn H, Falke D, Kaufmann SHE, Ullmann U. 2005, Springer Medizin-Verlag. Berlin, 5: 750-753. Liesenfeld O, Janitschke K: Toxoplasma. Medizinische Mikrobiologie und Infektiologie. Auflage. Edited by: Hahn H, Falke D, Kaufmann SHE, Ullmann U. 2005, Springer Medizin-Verlag. Berlin, 5: 750-753.
2.
go back to reference Hill DE, Chirukandoth S, Dubey JP: Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005, 6: 41-61. 10.1079/AHR2005100.CrossRefPubMed Hill DE, Chirukandoth S, Dubey JP: Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005, 6: 41-61. 10.1079/AHR2005100.CrossRefPubMed
3.
go back to reference Montoya JG, Liesenfeld O: Toxoplasmosis. Lancet. 2004, 363: 1965-1976. 10.1016/S0140-6736(04)16412-X.CrossRefPubMed Montoya JG, Liesenfeld O: Toxoplasmosis. Lancet. 2004, 363: 1965-1976. 10.1016/S0140-6736(04)16412-X.CrossRefPubMed
4.
go back to reference Dubey JP: Toxoplasmosis – a waterborne zoonosis. Vet Parasitol. 2004, 126: 57-72. 10.1016/j.vetpar.2004.09.005.CrossRefPubMed Dubey JP: Toxoplasmosis – a waterborne zoonosis. Vet Parasitol. 2004, 126: 57-72. 10.1016/j.vetpar.2004.09.005.CrossRefPubMed
5.
go back to reference Dawson D: Foodborne protozoan parasites. Int J Food Microbiol. 2005, 103: 207-227. 10.1016/j.ijfoodmicro.2004.12.032.CrossRefPubMed Dawson D: Foodborne protozoan parasites. Int J Food Microbiol. 2005, 103: 207-227. 10.1016/j.ijfoodmicro.2004.12.032.CrossRefPubMed
6.
go back to reference Kravetz JD, Federman DG: Toxoplasmosis in pregnancy. Am J Med. 2005, 118: 212-216. 10.1016/j.amjmed.2004.08.023.CrossRefPubMed Kravetz JD, Federman DG: Toxoplasmosis in pregnancy. Am J Med. 2005, 118: 212-216. 10.1016/j.amjmed.2004.08.023.CrossRefPubMed
7.
go back to reference Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R: Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001, 56: 296-305. 10.1097/00006254-200105000-00025.CrossRefPubMed Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R: Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001, 56: 296-305. 10.1097/00006254-200105000-00025.CrossRefPubMed
8.
go back to reference Remington JS, McLeod R, Desmonts G: Toxoplasmosis. Infectious diseases of the foetus and newborn infant. Edited by: Remington JS, Klein JO. 2000, Saunders, Philadelphia, 205-346. 5 Remington JS, McLeod R, Desmonts G: Toxoplasmosis. Infectious diseases of the foetus and newborn infant. Edited by: Remington JS, Klein JO. 2000, Saunders, Philadelphia, 205-346. 5
9.
go back to reference Liesenfeld O, Wong SY, Remington JS: Toxoplasmosis. Cecil textbook of medicine. Edited by: Goldmann L, Bennett JC. 2000, Philadelphia, PA, USA: W.B. Saunders, 1963-21 Liesenfeld O, Wong SY, Remington JS: Toxoplasmosis. Cecil textbook of medicine. Edited by: Goldmann L, Bennett JC. 2000, Philadelphia, PA, USA: W.B. Saunders, 1963-21
10.
go back to reference Alvarado Esquivel C, Sethi Shneh, Janitschke K, Hahn H, Liesenfeld O: Comparison of two commercially available avidity tests for Toxoplasma-specific IgG antibodies. Arch Med Re. 2002, 33: 520-523. 10.1016/S0188-4409(02)00411-3.CrossRef Alvarado Esquivel C, Sethi Shneh, Janitschke K, Hahn H, Liesenfeld O: Comparison of two commercially available avidity tests for Toxoplasma-specific IgG antibodies. Arch Med Re. 2002, 33: 520-523. 10.1016/S0188-4409(02)00411-3.CrossRef
11.
go back to reference Nash JQ, Chissel S, Jones J, Warburton F, Verlander NQ: Risk factors for toxoplasmosis in pregnant women in Kent, United Kingdom. Epidemiol Infect. 2005, 133: 475-483. 10.1017/S0950268804003620.CrossRefPubMedPubMedCentral Nash JQ, Chissel S, Jones J, Warburton F, Verlander NQ: Risk factors for toxoplasmosis in pregnant women in Kent, United Kingdom. Epidemiol Infect. 2005, 133: 475-483. 10.1017/S0950268804003620.CrossRefPubMedPubMedCentral
12.
go back to reference Gutierrez-Zufiaurre N, Sanchez-Hernandez J, Munoz S, Marin R, Delgado N, Saenz MC, Munoz-Bellido JL, Garcia-Rodriguez JA: Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women. Enferm Infecc Microbiol Clin. 2004, 22: 512-516. 10.1157/13067618.CrossRefPubMed Gutierrez-Zufiaurre N, Sanchez-Hernandez J, Munoz S, Marin R, Delgado N, Saenz MC, Munoz-Bellido JL, Garcia-Rodriguez JA: Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women. Enferm Infecc Microbiol Clin. 2004, 22: 512-516. 10.1157/13067618.CrossRefPubMed
13.
go back to reference Ertug S, Okyay P, Turkmen M, Yuksel H: Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005, 5: 66-10.1186/1471-2458-5-66.CrossRefPubMedPubMedCentral Ertug S, Okyay P, Turkmen M, Yuksel H: Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005, 5: 66-10.1186/1471-2458-5-66.CrossRefPubMedPubMedCentral
14.
go back to reference Petersson K, Stray-Pedersen B, Malm G, Forsgren M, Evengard B: Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstet Gynecol Scand. 2000, 79: 824-829. 10.1034/j.1600-0412.2000.079010824.x.PubMed Petersson K, Stray-Pedersen B, Malm G, Forsgren M, Evengard B: Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstet Gynecol Scand. 2000, 79: 824-829. 10.1034/j.1600-0412.2000.079010824.x.PubMed
15.
go back to reference Punda-Polic V, Tonkic M, Capkun V: Prevalence of antibodies to Toxoplasma gondii in the female population of the County of Split Dalmatia, Croatia. Eur J Epidemiol. 2000, 16: 875-877. 10.1023/A:1007606501923.CrossRefPubMed Punda-Polic V, Tonkic M, Capkun V: Prevalence of antibodies to Toxoplasma gondii in the female population of the County of Split Dalmatia, Croatia. Eur J Epidemiol. 2000, 16: 875-877. 10.1023/A:1007606501923.CrossRefPubMed
16.
go back to reference Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, Foulon W, Semprini AE, Dunn DT: Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000, 321: 142-147. 10.1136/bmj.321.7254.142.CrossRefPubMedPubMedCentral Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, Foulon W, Semprini AE, Dunn DT: Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000, 321: 142-147. 10.1136/bmj.321.7254.142.CrossRefPubMedPubMedCentral
17.
go back to reference Harma M, Harma M, Gungen N, Demir N: Toxoplasmosis in pregnant women in Sanliurfa, Southeastern Anatolia City, Turkey. J Egypt Soc Parasitol. 2004, 34: 519-525.PubMed Harma M, Harma M, Gungen N, Demir N: Toxoplasmosis in pregnant women in Sanliurfa, Southeastern Anatolia City, Turkey. J Egypt Soc Parasitol. 2004, 34: 519-525.PubMed
18.
go back to reference Munoz Batet C, Guardia Llobet C, Juncosa Morros T, Vinas Domenech L, Sierra Soler M, Sanfeliu Sala I, Bosch Mestres J, Dopico Ponte E, Lite Lite J, Matas Andreu L, Juste Sanchez C, Barranco Romeu M: Toxoplasmosis and pregnancy. Multicenter study of 16,362 pregnant women in Barcelona. Med Clin. 2004, 123: 12-16.CrossRef Munoz Batet C, Guardia Llobet C, Juncosa Morros T, Vinas Domenech L, Sierra Soler M, Sanfeliu Sala I, Bosch Mestres J, Dopico Ponte E, Lite Lite J, Matas Andreu L, Juste Sanchez C, Barranco Romeu M: Toxoplasmosis and pregnancy. Multicenter study of 16,362 pregnant women in Barcelona. Med Clin. 2004, 123: 12-16.CrossRef
19.
go back to reference Jenum PA, Kapperud G, Stray-Pedersen B, Melby KK, Eskild A, Eng J: Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect. 1998, 120: 87-92. 10.1017/S0950268897008480.CrossRefPubMedPubMedCentral Jenum PA, Kapperud G, Stray-Pedersen B, Melby KK, Eskild A, Eng J: Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect. 1998, 120: 87-92. 10.1017/S0950268897008480.CrossRefPubMedPubMedCentral
20.
go back to reference Jeannel D, Niel G, Costagliola D, Danis M, Traore BM, Gentilini M: Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol. 1988, 17: 595-602.CrossRefPubMed Jeannel D, Niel G, Costagliola D, Danis M, Traore BM, Gentilini M: Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol. 1988, 17: 595-602.CrossRefPubMed
22.
go back to reference Buchy P, Follezou JY, Lien TX, An TT, Tram LT, Tri DV, Cuong NM, Glaziou P, Chien BT: Serological study of toxoplasmosis in Vietnam in a population of drug users (Ho Chi Minh city) and pregnant women (Nha Trang). Bull Soc Pathol Exot. 2003, 96: 46-47.PubMed Buchy P, Follezou JY, Lien TX, An TT, Tram LT, Tri DV, Cuong NM, Glaziou P, Chien BT: Serological study of toxoplasmosis in Vietnam in a population of drug users (Ho Chi Minh city) and pregnant women (Nha Trang). Bull Soc Pathol Exot. 2003, 96: 46-47.PubMed
23.
go back to reference Singh S, Pandit AJ: Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study. Am J Reprod Immunol. 2004, 52: 276-283. 10.1111/j.1600-0897.2004.00222.x.CrossRefPubMed Singh S, Pandit AJ: Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study. Am J Reprod Immunol. 2004, 52: 276-283. 10.1111/j.1600-0897.2004.00222.x.CrossRefPubMed
24.
go back to reference Akoijam BS, Shashikant , Singh S, Kapoor SK: Seroprevalence of toxoplasma infection among primigravid women attending antenatal clinic at a secondary level hospital in North India. J Indian Med Assoc. 2002, 100: 591-592.PubMed Akoijam BS, Shashikant , Singh S, Kapoor SK: Seroprevalence of toxoplasma infection among primigravid women attending antenatal clinic at a secondary level hospital in North India. J Indian Med Assoc. 2002, 100: 591-592.PubMed
25.
go back to reference Nissapatorn V, Noor Azmi MA, Cho SM, Fong MY, Init I, Rohela M, Khairul Anuar A, Quek KF, Latt HM: Toxoplasmosis: prevalence and risk factors. J Obstet Gynaecol. 2003, 23: 618-624. 10.1080/01443610310001604376.CrossRefPubMed Nissapatorn V, Noor Azmi MA, Cho SM, Fong MY, Init I, Rohela M, Khairul Anuar A, Quek KF, Latt HM: Toxoplasmosis: prevalence and risk factors. J Obstet Gynaecol. 2003, 23: 618-624. 10.1080/01443610310001604376.CrossRefPubMed
26.
go back to reference Rai SK, Shibata H, Sumi K, Rai G, Rai N, Manandhar R, Gurung G, Ono K, Uga S, Matsuoka A, Shrestha HG, Matsumura T: Toxoplasma antibody prevalence in Nepalese pregnant women and women with bad obstetric history. Southeast Asian J Trop Med Public Health. 1998, 29: 739-743.PubMed Rai SK, Shibata H, Sumi K, Rai G, Rai N, Manandhar R, Gurung G, Ono K, Uga S, Matsuoka A, Shrestha HG, Matsumura T: Toxoplasma antibody prevalence in Nepalese pregnant women and women with bad obstetric history. Southeast Asian J Trop Med Public Health. 1998, 29: 739-743.PubMed
27.
go back to reference Elnahas A, Gerais AS, Elbashir MI, Eldien ES, Adam I: Toxoplasmosis in pregnant Sudanese women. Saudi Med J. 2003, 24: 868-870.PubMed Elnahas A, Gerais AS, Elbashir MI, Eldien ES, Adam I: Toxoplasmosis in pregnant Sudanese women. Saudi Med J. 2003, 24: 868-870.PubMed
28.
go back to reference Morris A, Croxson M: Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland. N Z Med J. 2004, 117: U770-PubMed Morris A, Croxson M: Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland. N Z Med J. 2004, 117: U770-PubMed
29.
go back to reference Spalding SM, Amendoeira MR, Klein CH, Ribeiro LC: Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil. Rev Soc Bras Med Trop. 2005, 38: 173-177. 10.1590/S0037-86822005000200009.CrossRefPubMed Spalding SM, Amendoeira MR, Klein CH, Ribeiro LC: Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil. Rev Soc Bras Med Trop. 2005, 38: 173-177. 10.1590/S0037-86822005000200009.CrossRefPubMed
30.
go back to reference Gonzalez-Morales T, Bacallo-Gallestey J, Garcia-Santana CA, Molina-Garcia JR: Prevalence of Toxoplasma gondii antibodies in a population of pregnant women in Cuba. Gac Med Mex. 1995, 131: 499-503.PubMed Gonzalez-Morales T, Bacallo-Gallestey J, Garcia-Santana CA, Molina-Garcia JR: Prevalence of Toxoplasma gondii antibodies in a population of pregnant women in Cuba. Gac Med Mex. 1995, 131: 499-503.PubMed
31.
go back to reference Bronfman M, Guiscafré H, Castro V, Castro R, Gutiérrez G: La medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med. 1988, 19: 351-360. Bronfman M, Guiscafré H, Castro V, Castro R, Gutiérrez G: La medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med. 1988, 19: 351-360.
32.
go back to reference Vela-Amieva M, Canedo-Solares I, Gutierrez-Castrellon P, Perez-Andrade M, Gonzalez-Contreras C, Ortiz-Cortes J, Ortega-Velazquez V, Galvan-Ramirez Mde L, Ruiz-Garcia M, Saltigeral-Simentel P, Ordaz-Favila JC, Sanchez C, Correa D: Short report: neonatal screening pilot study of Toxoplasma gondii congenital infection in Mexico. Am J Trop Med Hyg. 2005, 72: 142-144.PubMed Vela-Amieva M, Canedo-Solares I, Gutierrez-Castrellon P, Perez-Andrade M, Gonzalez-Contreras C, Ortiz-Cortes J, Ortega-Velazquez V, Galvan-Ramirez Mde L, Ruiz-Garcia M, Saltigeral-Simentel P, Ordaz-Favila JC, Sanchez C, Correa D: Short report: neonatal screening pilot study of Toxoplasma gondii congenital infection in Mexico. Am J Trop Med Hyg. 2005, 72: 142-144.PubMed
33.
go back to reference Velasco-Castrejon O, Salvatierra-Izaba B, Valdespino JL, Sedano-Lara AM, Galindo-Virgen S, Magos C, Llausas A, Tapia-Conyer R, Gutierrez G, Sepulveda J: Seroepidemiology of toxoplasmosis in Mexico. Salud Publica Mex. 1992, 34: 222-229.CrossRefPubMed Velasco-Castrejon O, Salvatierra-Izaba B, Valdespino JL, Sedano-Lara AM, Galindo-Virgen S, Magos C, Llausas A, Tapia-Conyer R, Gutierrez G, Sepulveda J: Seroepidemiology of toxoplasmosis in Mexico. Salud Publica Mex. 1992, 34: 222-229.CrossRefPubMed
34.
go back to reference Goldsmith RS, Kagan IG, Zarate R, Reyes-Gonzalez MA, Cedeno-Ferreira J: Low Toxoplasma antibody prevalence in serologic surveys of humans in southern Mexico. Arch Invest Med. 1991, 22: 63-73. Goldsmith RS, Kagan IG, Zarate R, Reyes-Gonzalez MA, Cedeno-Ferreira J: Low Toxoplasma antibody prevalence in serologic surveys of humans in southern Mexico. Arch Invest Med. 1991, 22: 63-73.
35.
go back to reference Fernandez Torrano M: Epidemiology of Toxoplasmosis in pregnant women in Tabasco, Mexico. J Trop Pediatr. 1988, 34: 143-146.CrossRef Fernandez Torrano M: Epidemiology of Toxoplasmosis in pregnant women in Tabasco, Mexico. J Trop Pediatr. 1988, 34: 143-146.CrossRef
36.
go back to reference Galvan Ramirez M, de la L, Soto Mancilla JL, Velasco Castrejon O, Perez Medina R: Incidence of anti-Toxoplasma antibodies in women with high-risk pregnancy and habitual abortions. Rev Soc Bras Med Trop. 1995, 28: 333-337.CrossRefPubMed Galvan Ramirez M, de la L, Soto Mancilla JL, Velasco Castrejon O, Perez Medina R: Incidence of anti-Toxoplasma antibodies in women with high-risk pregnancy and habitual abortions. Rev Soc Bras Med Trop. 1995, 28: 333-337.CrossRefPubMed
37.
go back to reference Zavala-Velazquez J, Guzman-Marin E, Barrera-Perez M, Rodriguez-Felix ME: Toxoplasmosis and abortion in patients at the O'Horan Hospital of Merida, Yucatan. Salud Publica Mex. 1989, 31: 664-668.PubMed Zavala-Velazquez J, Guzman-Marin E, Barrera-Perez M, Rodriguez-Felix ME: Toxoplasmosis and abortion in patients at the O'Horan Hospital of Merida, Yucatan. Salud Publica Mex. 1989, 31: 664-668.PubMed
38.
go back to reference Dubey JP: Toxoplasma gondii oocyst survival under defined temperatures. J Parasitol. 1998, 84: 862-865. 10.2307/3284606.CrossRefPubMed Dubey JP: Toxoplasma gondii oocyst survival under defined temperatures. J Parasitol. 1998, 84: 862-865. 10.2307/3284606.CrossRefPubMed
39.
go back to reference Hershey DW, McGregor JA: Low prevalence of Toxoplasma infection in a Rocky Mountain prenatal population. Obstet Gynecol. 1987, 70: 900-902.PubMed Hershey DW, McGregor JA: Low prevalence of Toxoplasma infection in a Rocky Mountain prenatal population. Obstet Gynecol. 1987, 70: 900-902.PubMed
40.
go back to reference Rai SK, Shibata H, Sumi K, Kubota K, Hirai K, Matsuoka A, Kubo T, Tamura T, Basnet SR, Shrestha HG, et al: Seroepidemiological study of toxoplasmosis in two different geographical areas in Nepal. Southeast Asian J Trop Med Public Health. 1994, 25: 479-484.PubMed Rai SK, Shibata H, Sumi K, Kubota K, Hirai K, Matsuoka A, Kubo T, Tamura T, Basnet SR, Shrestha HG, et al: Seroepidemiological study of toxoplasmosis in two different geographical areas in Nepal. Southeast Asian J Trop Med Public Health. 1994, 25: 479-484.PubMed
41.
go back to reference Rajkhowa S, Sarma DK, Rajkhowa C: Seroprevalence of Toxoplasma gondii antibodies in captive mithuns (Bos frontalis) from India. Vet Parasitol. 2006, 135: 369-374. 10.1016/j.vetpar.2005.10.007.CrossRefPubMed Rajkhowa S, Sarma DK, Rajkhowa C: Seroprevalence of Toxoplasma gondii antibodies in captive mithuns (Bos frontalis) from India. Vet Parasitol. 2006, 135: 369-374. 10.1016/j.vetpar.2005.10.007.CrossRefPubMed
42.
go back to reference Lopez-Castillo CA, Diaz-Ramirez J, Gomez-Marin JE: Risk factors for Toxoplasma gondii infection in pregnant women in Armenia, Colombia. Rev Salud Publica. 2005, 7: 180-190.CrossRefPubMed Lopez-Castillo CA, Diaz-Ramirez J, Gomez-Marin JE: Risk factors for Toxoplasma gondii infection in pregnant women in Armenia, Colombia. Rev Salud Publica. 2005, 7: 180-190.CrossRefPubMed
43.
go back to reference Baril L, Ancelle T, Goulet V, Thulliez P, Tirard-Fleury V, Carme B: Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis. 1999, 31: 305-309. 10.1080/00365549950163626.CrossRefPubMed Baril L, Ancelle T, Goulet V, Thulliez P, Tirard-Fleury V, Carme B: Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis. 1999, 31: 305-309. 10.1080/00365549950163626.CrossRefPubMed
44.
go back to reference Liesenfeld O, Press C, Flanders R, Ramirez R, Remington JS: Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M Toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis. J Clin Microbiol. 1996, 34: 2526-2530.PubMedPubMedCentral Liesenfeld O, Press C, Flanders R, Ramirez R, Remington JS: Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M Toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis. J Clin Microbiol. 1996, 34: 2526-2530.PubMedPubMedCentral
Metadata
Title
Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico
Authors
Cosme Alvarado-Esquivel
Antonio Sifuentes-Álvarez
Sergio Guadalupe Narro-Duarte
Sergio Estrada-Martínez
Juan Humberto Díaz-García
Oliver Liesenfeld
Sergio Arturo Martínez-García
Arturo Canales-Molina
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2006
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-6-113

Other articles of this Issue 1/2006

BMC Infectious Diseases 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.